{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:03:17Z","timestamp":1790866997577,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["AZV 15-26693 A, RVO00023728"],"award-info":[{"award-number":["AZV 15-26693 A, RVO00023728"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["RVO VFN64165"],"award-info":[{"award-number":["RVO VFN64165"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1860-8","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T10:06:02Z","timestamp":1553076362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients"],"prefix":"10.1186","volume":"21","author":[{"given":"Blanka","family":"Stiburkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Pavelcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marketa","family":"Pavlikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Je\u0161ina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pavelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"key":"1860_CR1","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008. Arthritis Rheum. 2011;63:3136\u201341.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1860_CR2","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1136\/ard.2009.109884","volume":"69","author":"AE Hak","year":"2010","unstructured":"Hak AE, Curhan GC, Grodstein F, et al. Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis. 2010;69(7):1305\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1860_CR3","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1136\/ard.2006.051649","volume":"65","author":"LR Harrold","year":"2006","unstructured":"Harrold LR, Yood RA, Mikuls TR, et al. Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis. 2006;65(10):1368\u201372.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1860_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12891-017-1465-9","volume":"18","author":"LR Harrold","year":"2017","unstructured":"Harrold LR, Etzel CJ, Gibofsky A, et al. Sex differences in gout characteristics: tailoring care for women and men. BMC Musculoskelet Disord. 2017;18(1):108.","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"1860_CR5","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/rheumatology\/key041","volume":"57","author":"M Zik\u00e1nov\u00e1","year":"2018","unstructured":"Zik\u00e1nov\u00e1 M, Wahezi D, Hay A, et al. Clinical manifestations and molecular aspects of phosphoribosylpyrophosphate synthetase superactivity in females. Rheumatology (Oxford). 2018;57(7):1180\u20135.","journal-title":"Rheumatology (Oxford)"},{"key":"1860_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2014.11.026","volume":"440","author":"E Kostalova","year":"2015","unstructured":"Kostalova E, Pavelka K, Vlaskova H, et al. Hyperuricemia and gout due to deficiency of hypoxanthine-guanine phosphoribosyltransferase in female carriers: new insight to differential diagnosis. Clin Chim Acta. 2015;440:214\u20137.","journal-title":"Clin Chim Acta"},{"issue":"11","key":"1860_CR7","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.2337\/diabetes.52.11.2840","volume":"52","author":"W Tang","year":"2003","unstructured":"Tang W, Miller MB, Rich SS, et al. Linkage analysis of a composite factor for the multiple metabolic syndrome: the National Heart, Lung, and Blood Institute Family Heart Study. Diabetes. 2003;52(11):2840\u20137.","journal-title":"Diabetes."},{"issue":"3","key":"1860_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s004390051050","volume":"106","author":"JB Wilk","year":"2000","unstructured":"Wilk JB, Djousse L, Borecki I, et al. Segregation analysis of serum uric acid in the NHLBI Family Heart Study. Hum Genet. 2000;106(3):355\u20139.","journal-title":"Hum Genet"},{"issue":"11","key":"1860_CR9","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.metabol.2005.05.007","volume":"54","author":"Q Yang","year":"2005","unstructured":"Yang Q, Guo CY, Cupples LA, et al. Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study. Metabolism. 2005;54(11):1435\u20134.","journal-title":"Metabolism."},{"issue":"2","key":"1860_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/ng.2500","volume":"45","author":"A K\u00f6ttgen","year":"2013","unstructured":"K\u00f6ttgen A, Albrecht E, Teumer A, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45(2):145\u201354.","journal-title":"Nat Genet"},{"issue":"5","key":"1860_CR11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/annrheumdis-2016-209632","volume":"76","author":"A Nakayama","year":"2017","unstructured":"Nakayama A, Nakaoka H, Yamamoto K, et al. GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes. Ann Rheum Dis. 2017;76(5):869\u201377.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1860_CR12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/ncomms1756","volume":"3","author":"K Ichida","year":"2012","unstructured":"Ichida K, Matsuo H, Takada T, et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun. 2012;3(3):764.","journal-title":"Nat Commun"},{"issue":"3","key":"1860_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneph.2015.205","volume":"12","author":"A Vivante","year":"2016","unstructured":"Vivante A, Hildebrandt F. Exploring the genetic basis of early-onset chronic kidney disease. Nat Rev Nephrol. 2016;12(3):133\u201346.","journal-title":"Nat Rev Nephrol"},{"key":"1860_CR14","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1038\/srep02014","volume":"3","author":"H Matsuo","year":"2013","unstructured":"Matsuo H, Ichida K, Takada T, et al. Common dysfunctional variants in ABCG2 are a major cause of early-onset gout. Sci Rep. 2013;3:2014.","journal-title":"Sci Rep"},{"issue":"11","key":"1860_CR15","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/kex295","volume":"56","author":"B Stiburkova","year":"2017","unstructured":"Stiburkova B, Pavelcova K, Zavada J, et al. Functional non-synonymous variants of ABCG2 and gout risk. Rheumatology (Oxford). 2017;56(11):1982\u201392.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"1860_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2133\/dmpk.DMPK-14-SC-041","volume":"29","author":"M Sakiyama","year":"2014","unstructured":"Sakiyama M, Matsuo H, Takada Y, et al. Ethnic differences in ATPbinding cassette transporter, sub-family G, member 2 (ABCG2\/BCRP): genotype combinations and estimated functions. Drug Metab Pharmacokinet. 2014;29(6):490\u20132.","journal-title":"Drug Metab Pharmacokinet"},{"key":"1860_CR17","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1038\/srep05227","volume":"4","author":"A Nakayama","year":"2014","unstructured":"Nakayama A, Matsuo H, Nakaoka H, et al. Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors. Sci Rep. 2014;4:5227.","journal-title":"Sci Rep"},{"issue":"4","key":"1860_CR18","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1136\/annrheumdis-2014-206191","volume":"75","author":"H Matsuo","year":"2016","unstructured":"Matsuo H, Yamamoto K, Nakaoka H, et al. Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes. Ann Rheum Dis. 2016;75(4):652\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1860_CR19","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.1038\/ncomms8041","volume":"13","author":"C Li","year":"2015","unstructured":"Li C, Li Z, Liu S, et al. Genome-wide association analysis identifies three new risk loci for gout arthritis in Han Chinese. Nat Commun. 2015;13(6):7041.","journal-title":"Nat Commun"},{"key":"1860_CR20","doi-asserted-by":"publisher","first-page":"5ra11","DOI":"10.1126\/scitranslmed.3000237","volume":"1","author":"H Matsuo","year":"2009","unstructured":"Matsuo H, Takada T, Ichida K, et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med. 2009;1:5ra11.","journal-title":"Sci Transl Med"},{"issue":"2","key":"1860_CR21","doi-asserted-by":"publisher","first-page":"e000464","DOI":"10.1136\/rmdopen-2017-000464","volume":"3","author":"T Higashino","year":"2017","unstructured":"Higashino T, Takada T, Nakaoka H, et al. Multiple common and rare variants of ABCG2 cause gout. RMD Open. 2017;3(2):e000464.","journal-title":"RMD Open"},{"issue":"3","key":"1860_CR22","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20(3):895\u2013900.","journal-title":"Arthritis Rheum"},{"issue":"25","key":"1860_CR23","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1073\/pnas.0901249106","volume":"106","author":"OM Woodward","year":"2009","unstructured":"Woodward OM, K\u00f6ttgen A, Coresh J, et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A. 2009;106(25):10338\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"1860_CR24","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1002\/art.40572","volume":"70","author":"A Abhishek","year":"2018","unstructured":"Abhishek A, Courtney P, Jenkins W, et al. Monosodium urate crystal deposits are common in asymptomatic sons of people with gout - the sons of gout study. Arthritis Rheumatol. 2018;70(11):1847\u201352.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"1860_CR25","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3945\/ajcn.114.095364","volume":"101","author":"VS Voruganti","year":"2015","unstructured":"Voruganti VS, Laston S, Haack K, et al. Serum uric acid concentrations and SLC2A9 genetic variation in Hispanic children: the Viva La Familia study. Am J Clin Nutr. 2015;101(4):725\u201332.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"1860_CR26","doi-asserted-by":"publisher","first-page":"e107902","DOI":"10.1371\/journal.pone.0107902","volume":"9","author":"O Hurba","year":"2014","unstructured":"Hurba O, Mancikova A, Krylov V, et al. Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout. PLoS One. 2014;9(9):e107902.","journal-title":"PLoS One"},{"issue":"8","key":"1860_CR27","first-page":"3458","volume":"61","author":"M Maliepaard","year":"2001","unstructured":"Maliepaard M, Scheffer GL, Faneyte IF, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 2001;61(8):3458\u201364.","journal-title":"Cancer Res"},{"key":"1860_CR28","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1038\/srep03755","volume":"4","author":"H Matsuo","year":"2014","unstructured":"Matsuo H, Nakayama A, Sakiyama M, et al. ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload. Sci Rep. 2014;4:3755.","journal-title":"Sci Rep"},{"issue":"2","key":"1860_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/tpj.2015.101","volume":"17","author":"RL Roberts","year":"2016","unstructured":"Roberts RL, Wallace MC, Phipps-Green AJ, et al. ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout. Pharmacogenomics J. 2016;17(2):201\u20133.","journal-title":"Pharmacogenomics J"},{"issue":"5","key":"1860_CR30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/cpt.89","volume":"97","author":"CC Wen","year":"2015","unstructured":"Wen CC, Yee SW, Liang X, et al. Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response. Clin Pharmacol Ther. 2015;97(5):518\u201325.","journal-title":"Clin Pharmacol Ther"},{"key":"1860_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cca.2016.06.007","volume":"460","author":"L Petru","year":"2016","unstructured":"Petru L, Pavelcova K, Sebesta I, Stiburkova B. Genetic background of uric acid metabolism in a patient with severe chronic tophaceous gout. Clin Chim Acta. 2016;460:46\u20139.","journal-title":"Clin Chim Acta"},{"issue":"6","key":"1860_CR32","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/art.10792","volume":"47","author":"F Perez-Ruiz","year":"2002","unstructured":"Perez-Ruiz F, Calabozo M, Erauskin GG, Ruibal A, Herrero-Beites AM. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis & Rheum. 2002;47(6):610\u20133.","journal-title":"Arthritis & Rheum"},{"issue":"7","key":"1860_CR33","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/annrheumdis-2015-208111","volume":"75","author":"DRW Kannangara","year":"2016","unstructured":"Kannangara DRW, Phipps-Green AJ, Dalbeth N, et al. Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urate. Ann Rheum Dis. 2016;75(7):1363\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1860_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.semarthrit.2016.07.015","volume":"46","author":"L Stamp","year":"2017","unstructured":"Stamp L, Dalbeth N. Urate-lowering therapy for asymptomatic hyperuricaemia: a need for caution. Semin Arthritis Rheum. 2017;46(4):457\u201364.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1860-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1860-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1860-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:11:21Z","timestamp":1584576681000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1860-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1860"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1860-8","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,20]]},"assertion":[{"value":"19 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Institute of Rheumatology (reference number 6181\/2015). All patients and healthy controls were fully informed of the aim of the study, and written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"77"}}